Of all DS patients, 95% carry a de novo heterozygous mutation in SCN1A [2], which encodes the pore forming α-subunit of neuronal voltage gated sodium channel (VGSC) type 1 (NaV1.1). This evidence concerns the gene SCN1A and Dravet syndrome.